Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease

Active, not recruitingOBSERVATIONAL
Enrollment

286

Participants

Timeline

Start Date

March 23, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Alpha 1-Antitrypsin DeficiencyGenetic Disease
Trial Locations (9)

10032

Columbia University, New York

27514

University of North Carolina, Chapel Hill

29425

Medical University of South Carolina, Charleston

35233

University of Alabama at Birmingham, Birmingham

60637

University of Chicago, Chicago

80206

National Jewish Health, Denver

84108

University of Utah, Salt Lake City

90095

University of California - Los Angeles, Los Angeles

02118

Boston University, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alpha-1 Foundation

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Columbia University

OTHER

NCT05297812 - Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease | Biotech Hunter | Biotech Hunter